Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The best basic science paper in multiple sclerosis in 2014: Important role for the choroid plexus in the central nervous system entry of leukocytes.
Inpatient Rehabilitation Utilization for Medicare Beneficiaries with Multiple Sclerosis.
Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.
Impact of Repeated Topical-Loaded Manganese-Enhanced MRI on the Mouse Visual System.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
Daily hassles reported by Dutch multiple sclerosis patients.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
Fingolimod (FTY720) stimulates ca(2+)/calcineurin signaling in fission yeast.
Clinical characteristics and outcome of multiple sclerosis in Korea: does multiple sclerosis in Korea really differ from that in the Caucasian populations?
Biologic therapies: lessons from multiple sclerosis.
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation.
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
[Neuromyelitis optica.]
First patient enrolled in third Phase III study of oral laquinimod for relapsing-remitting multiple sclerosis
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.

Pages